Flagship Pioneering, LLC Long-Term Concentrated

CIK: 0001400240 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 10, 2017

Total Value ($000): $376,254 (100.0% shares, 0.0% debt)

Holdings (7)

— SERES THERAPEUTICS INC 38.0%

Value ($000) $142,936 Shares 12,682,876 Est. Cost $12.29 Unrealized —

— SYROS PHARMACEUTICALS INC 20.4%

Value ($000) $76,570 Shares 4,806,656 Est. Cost $13.87 Unrealized —

EDIT EDITAS MEDICINE INC 20.0%

Value ($000) $75,356 Shares 3,376,184 Est. Cost $20.49 Unrealized +1.1%

AGIO AGIOS PHARMACEUTICALS INC 15.0%

Value ($000) $56,378 Shares 965,369 Est. Cost $43.55 Unrealized +10.1%

— SELECTA BIOSCIENCES INC 3.1%

Value ($000) $11,841 Shares 826,862 Est. Cost $14.25 Unrealized —

— T2 BIOSYSTEMS INC 2.7%

Value ($000) $10,260 Shares 1,950,583 Est. Cost $7.24 Unrealized —

— ELEVEN BIOTHERAPEUTICS INC 0.8%

Value ($000) $2,913 Shares 1,324,018 Est. Cost $2.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SERES THERAPEUTICS INC	12,682,876	$142,936	38.0%	$12.29	—	COM	81750R102
—	SYROS PHARMACEUTICALS INC	4,806,656	$76,570	20.4%	$13.87	—	COM	87184Q107
EDIT	EDITAS MEDICINE INC	3,376,184	$75,356	20.0%	$20.49	+1.1%	COM	28106W103
AGIO	AGIOS PHARMACEUTICALS INC	965,369	$56,378	15.0%	$43.55	+10.1%	COM	00847X104
—	SELECTA BIOSCIENCES INC	826,862	$11,841	3.1%	$14.25	—	COM	816212104
—	T2 BIOSYSTEMS INC	1,950,583	$10,260	2.7%	$7.24	—	COM	89853L104
—	ELEVEN BIOTHERAPEUTICS INC	1,324,018	$2,913	0.8%	$2.80	—	COM	286221106